Samantha G. Zambuto, Adrienne K. Scott, Michelle L. Oyen
{"title":"FDA现代化法案2.0和生殖研究","authors":"Samantha G. Zambuto, Adrienne K. Scott, Michelle L. Oyen","doi":"10.1038/s44222-024-00252-8","DOIUrl":null,"url":null,"abstract":"The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.","PeriodicalId":74248,"journal":{"name":"Nature reviews bioengineering","volume":"2 12","pages":"984-986"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FDA Modernization Act 2.0 and reproductive research\",\"authors\":\"Samantha G. Zambuto, Adrienne K. Scott, Michelle L. Oyen\",\"doi\":\"10.1038/s44222-024-00252-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.\",\"PeriodicalId\":74248,\"journal\":{\"name\":\"Nature reviews bioengineering\",\"volume\":\"2 12\",\"pages\":\"984-986\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature reviews bioengineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.nature.com/articles/s44222-024-00252-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature reviews bioengineering","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44222-024-00252-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
FDA Modernization Act 2.0 and reproductive research
The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
